Treating life-threatening conditions
CorMedix Therapeutics (melinta.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 39th percentile of 17178 Healthcare brands.
CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The company emphasizes addressing unmet medical needs through a specialized product pipeline. Its stated target audience includes healthcare providers, patients facing severe illnesses, and investors interested in biopharmaceutical innovation. The company positions itself within the broader healthcare and biopharmaceutical industry, aiming to deliver innovative therapeutic solutions for serious medical conditions.
| Brand Name | CorMedix Therapeutics |
|---|---|
| Domain | melinta.com |
| Industry | Healthcare |
| Main Competitors | Melinta Therapeutics (74/100), La Jolla Pharmaceutical Company (56/100), Paratek Pharmaceuticals (75/100), Cidara Therapeutics, Nabriva Therapeutics (53/100), Tetraphase Pharmaceuticals |
Moz Domain Authority 42/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #2,058,702 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "CorMedix Therapeutics is focused on developing and commercializing therapeutic products for life-threatening diseases and conditions." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, YouTube, GitHub; no detected presence on LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is CorMedix Therapeutics?", Claude could not identify the brand as of October 2026. I don't recognize a company matching this exact combination, the name CorMedix Therapeutics appears to mix up two different real pharmaceutical companies, CorMedix Inc and Melinta Therapeutics, and the website given doesn't match the name provided.
When asked "Best brands similar to CorMedix Therapeutics?", Claude would not surface CorMedix Therapeutics as of October 2026. Since the name and website don't align with a single company I can verify, I wouldn't recommend it without clarifying which actual company is meant.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
CorMedix Therapeutics's main competitors in Healthcare: Melinta Therapeutics (74/100), La Jolla Pharmaceutical Company (56/100), Paratek Pharmaceuticals (75/100), Nabriva Therapeutics (53/100).
Sources: Brand Analyzer scan
CorMedix Therapeutics has limited AI-search visibility, scoring 30/100 on Brand Analyzer's AI visibility composite (visibility 15, trust 40, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: CorMedix Therapeutics official site
CorMedix Therapeutics scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: CorMedix Therapeutics official site
CorMedix Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: CorMedix Therapeutics official site
CorMedix Therapeutics scores 30/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
CorMedix Therapeutics has a weak AI-visibility profile at 30/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (15/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,058,702 (Tranco) and a Moz Domain Authority of 42/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check (October 2026), Claude could not identify CorMedix Therapeutics from memory, confirming the gaps above.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to CorMedix Therapeutics: Medsien (74/100), Medsaf (74/100), Memmert (74/100), meQ (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.